Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect. (Q40929566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Xian-Cang Ma

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Xiao-Ling Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Wen-Hui Jiang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Min Jia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Yong-Hui Dang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Cheng-Ge Gao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

4 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

published in

Neurochemical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1375-1380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11064-016-1841-0

7 March 2020

exact match

0 references

cites work

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Differentiating antidepressants of the future: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Davunetide: Peptide therapeutic in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Anatomy and physiology of the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Habituation-Like Decrease of Acetylcholine-Induced Inward Current in Helix Command Neurons: Role of Microtubule Motor Proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

A breach in the scaffold: the possible role of cytoskeleton dysfunction in the pathogenesis of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Strategies to deliver peptide drugs to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Nasal drug administration: potential for targeted central nervous system delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Nanoparticles for direct nose-to-brain delivery of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Delivery of brain-derived neurotrophic factor via nose-to-brain pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Insights into direct nose to brain delivery: current status and future perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Adeno-associated viral vector-mediated expression of NT4-ADNF-9 fusion gene protects against aminoglycoside-induced auditory hair cell loss in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

The molecular motor toolbox for intracellular transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Tau and caspase 3 as targets for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

Molecular studies of major depressive disorder: the epigenetic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-016-1841-0

NAP accelerates the performance of normal rats in the water maze

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26846142

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The blood brain barrier: anatomy and physiology

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26846142

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11064-016-1841-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26846142%20AND%20SRC:MED&resulttype=core&format=json